Biosafety v global trade
US pitched against EU
The US government has backed biotech companies, while European countries have reservations about transgenic crops
Related Content
- Global Biodiversity Outlook 4
- The price and trade effects of strict information requirements for genetically modified commodities under the Cartagena Protocol on Biosafety
- National biodiversity plan admits India has failed to conserve biodiversity
- Unplanned exposure to genetically modified organisms: Divergent responses in the global south
- 'We see ourselves as a bridge between the EU and the US'
- Cartagena Protocol, US Bioterror Act May Influence Trade